与线粒体相关的编程细胞死亡作为与年龄有关的疾病的治疗点
Thanh T Nguyen1, Shibo Wei2, Thu Ha Nguyen3
1Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
Experimental & molecular medicine
|August 23, 2023
概括
线粒体是细胞生命和死亡的关键,影响各种编程细胞死亡途径. 了解这些线粒体的作用为与年龄有关的疾病提供了新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 线粒体生物学 线粒体生物学
- 病理学 病理学 病理学
背景情况:
- 线粒体是细胞能量生产和新陈代谢的核心.
- 线粒体调节各种细胞死亡途径,包括细胞亡和非细胞亡编程细胞死亡.
- 线粒体功能障碍与神经退行和心血管疾病等与年龄相关的疾病有关.
研究的目的:
- 审查线粒体质量控制网络.
- 详细介绍各种形式的线粒体相关编程细胞死亡.
- 突出这些过程在与年龄有关的疾病中的作用,并建议治疗途径.
主要方法:
- 关于线粒体质量控制机制的文献综述.
- 分析各种编程细胞死亡途径 (细胞亡,细胞亡,细胞亡,细胞亡,细胞亡,细胞亡,细胞亡).
- 检查线粒体细胞死亡和与年龄有关的疾病之间的联系.
主要成果:
- 线粒体质量控制网络 (mitohormesis,UPRmt,mitophagy) 维持细胞平衡.
- 多种编程的细胞死亡途径汇聚在线粒体.
- 线粒体细胞死亡机制在与年龄有关的疾病的发病过程中至关重要.
结论:
- 线粒体质量控制对于细胞健康至关重要.
- 针对线粒体相关的编程细胞死亡,为与年龄相关的疾病提供了有前途的治疗潜力.
- 对这些途径的进一步研究可以产生新的临床策略.
相关概念视频
Mitochondria
13.8K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.8K
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Overview of Cell Death
7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Mitochondrial Membranes
11.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


